Companies / Barinthus Biotherapeutics plc.

Barinthus Biotherapeutics plc.

Nasdaq: BRNSCIK 1828185GERMANTOWN, MD

Financials · FY2025

Revenue$0
Net income$-66.46M
Total debt$159.0K
Cash$59.30M
Diluted EPS$-1.64
Shares outstanding40.8M

Ownership

40.8M shares outstanding · as of Jul 30, 2026
19.4%Institutions
Ownership
Institutions19.36%7,909,725
Public float80.64%32,939,168

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 1

View all →
Insider% of sharesShares
Swirsky Douglas JFormerPrincipal Accounting Officer
——

Institutional holders 13

View all →
HolderValue% of shares
HSG Holding Ltd$42.22M3.48%
M&G Plc$5.20M12.72%
DC Funds, LP$449.6K1.57%
Renaissance Technologies LLC$85.9K0.37%
Johns Hopkins University$85.6K0.30%
Citadel Advisors LLC$83.2K0.29%
Baird Financial Group, Inc.$74.2K0.26%
Rangeley Capital, LLC$59.1K0.21%
HighTower Advisors, LLC$26.2K0.09%
Rhumbline Advisers$6.7K0.03%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
No activity matches these filters.

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
BRNSADREquity91864C107BBG00ZZPCP09